Aflac Incorporated offers diverse insurance products primarily in Japan and the U.S. As a major player in supplemental health and life insurance, the company shows consistent performance across its segments. Investors should watch its financial health and sector dynamics closely.
The fundamental rating of Aflac Incorporated indicates a moderate performance in terms of financial metrics. The overall score suggests room for improvement, especially in areas like debt management and valuation multiples.
Category | Score | Visualization |
---|---|---|
Discounted Cash Flow | 3 | |
Return on Equity | 3 | |
Return on Assets | 4 | |
Debt to Equity | 1 | |
Price to Earnings | 1 | |
Price to Book | 1 |
The historical scores indicate that the fundamental strengths have been consistent over time, with a focus on asset management and cash flow efficiency.
Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-08-19 | 2 | 3 | 3 | 4 | 1 | 1 | 1 |
Previous | 0 | 3 | 3 | 4 | 1 | 1 | 1 |
Analysts have set realistic price targets for Aflac, reflecting a balanced view between growth prospects and market risks.
High | Low | Median | Consensus |
---|---|---|---|
113 | 98 | 105 | 105.33 |
The current analyst sentiment leans towards holding the stock, indicating cautious optimism amidst prevailing market conditions.
Recommendation | Count | Visualization |
---|---|---|
Strong Buy | 0 | |
Buy | 10 | |
Hold | 16 | |
Sell | 4 | |
Strong Sell | 0 |
Aflac Incorporated shows a stable performance with particular strengths in cash flow and asset management, although there's room for improvement in debt levels and valuation. The stock's price targets imply moderate growth potential, while analyst consensus suggests maintaining current positions. Prospective investors should consider potential industry trends and company-specific developments that could influence future performance.